Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus Ointment 0.03%

Tacrolimus · Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tacrolimus Ointment 0.03%, covering 2014-09-01 to 2014-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment [Phase 3]

See pricing